Drug
ONO-1110
ONO-1110 is a pharmaceutical drug with 5 clinical trials. Currently 5 active trials ongoing.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
5(100%)
Phase Distribution
Ph phase_2
5
100%
Phase Distribution
0
Early Stage
5
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
5(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
5
trials recruiting
Total Trials
5
all time
Status Distribution
Active(5)
Detailed Status
Active, not recruiting5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
5
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 25 (100.0%)
Trials by Status
active_not_recruiting5100%
Recent Activity
5 active trials
Showing 5 of 5
active_not_recruitingphase_2
A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial Cystitis
NCT06752603
active_not_recruitingphase_2
A Clinical Study of ONO-1110 in Patients With Fibromyalgia
NCT06752590
active_not_recruitingphase_2
A Study of ONO-1110 in Patients With Postherpetic Neuralgia
NCT06708416
active_not_recruitingphase_2
A Study of ONO-1110 in Patients With Social Anxiety Disorder
NCT06805565
active_not_recruitingphase_2
A Study of ONO-1110 in Patients With Major Depressive Disorder
NCT06792136
Clinical Trials (5)
Showing 5 of 5 trials
NCT06752603Phase 2
A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial Cystitis
NCT06752590Phase 2
A Clinical Study of ONO-1110 in Patients With Fibromyalgia
NCT06708416Phase 2
A Study of ONO-1110 in Patients With Postherpetic Neuralgia
NCT06805565Phase 2
A Study of ONO-1110 in Patients With Social Anxiety Disorder
NCT06792136Phase 2
A Study of ONO-1110 in Patients With Major Depressive Disorder
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5